Gyre Therapeutics (GYRE) Gross Margin (2020 - 2026)
Gyre Therapeutics' Gross Margin was 92.41% in Q2 2026, up 6.25 percentage points from 86.16% a year earlier but down 2.14 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Gross Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gyre Therapeutics' Gross Margin was 94.30% through Jun 30, 2026, up 1.09 percentage points year-over-year; for FY2025, it was 95.35%, down 0.97 percentage points from FY2024.
- Gross Margin shows a five-year change of +39.10 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 96.33% in FY2024 (+0.41 pp), 95.91% in FY2023 (+0.60 pp), 95.31% in FY2022 (+95.89 pp) and -0.57% in FY2021 (-56.83 pp).
- Quarterly Gross Margin has moved between -0.57% (Q4 2021) and 96.95% (Q2 2024) over five years.
- Compared with a year earlier, Gross Margin was higher in two of the last eight quarters, with an average year-over-year change of -1.01 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q4 2022 (a gain of 96.64 percentage points); the worst was Q2 2025 (a drop of 10.78 percentage points).
- Per Business Quant data, GYRE's Gross Margin in the three quarters before Q2 2026 was 94.55% (Q1 2026), 95.31% (Q4 2025) and 94.67% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 92.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.41% |
| Mar 31, 2026 | 94.55% |
| Dec 31, 2025 | 95.31% |
| Sep 30, 2025 | 94.67% |
| Jun 30, 2025 | 86.16% |
| Mar 31, 2025 | 95.95% |
| Dec 31, 2024 | 95.78% |
| Sep 30, 2024 | 96.24% |
| Jun 30, 2024 | 96.95% |
| Mar 31, 2024 | 96.40% |
| Dec 31, 2023 | 95.40% |
| Sep 30, 2023 | 96.30% |
| Jun 30, 2023 | 96.33% |
| Mar 31, 2023 | 95.49% |
| Dec 31, 2022 | 96.06% |
| Mar 31, 2022 | -0.50% |
| Dec 31, 2021 | -0.57% |
| Sep 30, 2021 | -0.35% |
| Jun 30, 2021 | -0.62% |
| Mar 31, 2021 | -0.89% |
API Access
Gyre Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();